(Q74195354)
Statements
Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate (English)
P Dombernowsky
I Smith
G Falkson
R Leonard
L Panasci
J Bellmunt
W Bezwoda
G Gardin
A Gudgeon
M Morgan
A Fornasiero
W Hoffmann
J Michel
T Hatschek
T Tjabbes
H A Chaudri
U Hornberger
1 February 1998